ClinicalTrials.gg
Drug

Flecainide clinical trials

Also written Tambocor.

studies test it
20
open now
4
in phase 3
5
first study started
1998

How each study uses Flecainide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Flecainide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 Oct 1985 · TAMBOCOR · NDA 018830 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Flecainide
11
Flecainide Acetate
3

Brand

Tambocor
2

Studies by the year they started

19 studies that test it; most in 2018 (2)

Studies that test Flecainide, by start year
YearStudies
19981
20051
20061
20081
20111
20121
20161
20171
20182
20192
20201
20221
20232
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 2
5
Phase 3
5
Phase 4
6
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 17

Oslo University Hospital (1) · Assistance Publique - Hôpitaux de Paris (1) · University of Rochester (1) · Edgar Jaeggi (1) · InCarda Therapeutics, Inc. (1) · David Filgueiras-Rama (1) · Maatschap Cardiologie Zwolle (1) · Eastern Cooperative Oncology Group (1)

Often tested with

Tested in the same studies.

Sotalol (5) · Vernakalant (2) · Propafenone (2) · Amiodarone (2) · Digoxin (1) · Verapamil (1) · Dofetilide (1) · Disopyramide (1)

Studies

Open first, then newest update. How each study uses Flecainide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 20

Given beside what is tested · 1 — Flecainide is usual care or a partner of the new treatment
As the comparator · 6 — what is tested is compared with Flecainide

Codes

What other systems call Flecainide · ClinicalTrials.gg INT007498

  • MeSH (NLM) D005424FlecainideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) K94FTS1806FLECAINIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 4441Confirmed FDA, Wikidata
  • Wikidata Q421381flecainideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62029FlecainideOne source FDA
  • DrugBank DB01195One source Wikidata

Also registered as flecainide acetate (UNII M8U465Q1WQ · RxNorm 42686).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.